Overview

A Proof of Concept Study of Pradigastat in Patients With Functional Constipation

Status:
Recruiting
Trial end date:
2022-05-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety, and tolerability of pradigastat 20 and 40 mg as compared to placebo in patients with Functional Constipation.
Phase:
Phase 2
Details
Lead Sponsor:
Anji Pharma
Collaborator:
Covance